Adragos Hub

In the Japanese pharmaceutical market, a Marketing Authorization Holder (MAH) is legally required to commercialize pharmaceutical products. However, companies often face different regulatory and logistical situations regarding their MAH status. This chapter outlines two specific MAH transfer scenarios and demonstrates […]

When choosing a partner to support your pharmaceutical manufacturing, quality control is a crucial factor that can define the safety, effectiveness, and marketability of your product. This makes quality control important for ensuring safety, compliance, and operational efficiency throughout the […]

Biotechnology, a cornerstone of modern science, merges biological knowledge with engineering and technology to solve essential challenges across healthcare, agriculture, industry, and the environment. For pharmaceutical companies, understanding biotechnology is critical, whether for drug development, manufacturing, or leveraging innovative therapies. […]

Adragos Pharma is pleased to announce its participation in Bio-Europe 2025, taking place in Vienna, Austria, from November 3 to 5. As a global Contract Development and Manufacturing Organization (CDMO), we look forward to connecting with industry leaders, partners, and […]

For pharmaceutical companies with promising non-sterile liquid formulations, the path from the laboratory bench to commercial production can be both exhilarating and daunting. Whether you are a startup seeking your first commercial launch or an established pharma company expanding your […]

The pharmaceutical industry thrives on innovation, collaboration, and the strategic exchange of assets and technologies. As companies seek to maximize their commercial potential, minimize development risks, and expand their market reach, out licensing has become an essential component of modern […]